David Mitchell Dornan

age ~83

from San Ramon, CA

Get Report

Also known as:

David Mitchel Dornan
David M Dornan
David Te Dornan
David H Dornan
David P Dornan
David W Dornan
Dave M Dornan
David M Doman

Phone and address:: 2561 Derby Dr, San Ramon, CA 94583
925 275-0475

Connected to:

David Dornan Phones & Addresses

2561 Derby Dr, San Ramon, CA 94583 • 925 275-0475
San Jose, CA
338 I St, Fremont, CA 94536 • 510 713-1976 • 510 713-1972 • 510 796-6118
4445 Calypso Ter, Fremont, CA 94555
39653 Benavente Ave, Fremont, CA 94539 • 925 275-0475
37143 Waverly Ter #125, Fremont, CA 94536 • 925 275-0475
40938 Inglewood Cmn #23, Fremont, CA 94538
41834 Higgins Way, Fremont, CA 94539 • 510 651-7435 • 925 275-0475

Name / Title

Company / Classification

Phones & Addresses

David Dornan
Owner

Albor Restaurant
Ret Used Merchandise

2142 Ctr St, Berkeley, CA 94704

David Dornan
Owner

C'Est La Vie, LLC
Restaurant Management · Restaurants

2138 Ctr St, Berkeley, CA 94704
2142 Ctr St, Berkeley, CA 94704
510 848-8877

David Dornan
Owner

Bijan Co
Eating Place

39935 Msn Blvd, Fremont, CA 94539

David Huntley Dornan

Surf Technicians, LLC
Marketing and Wholesaling of Surfboard A · Wholesaling and Marketing of Surfboards · Manufacturer of Sporting/Athletic Goods · Mfg Sporting/Athletic Goods Business Services · Mfg Sporting/Athletic Goods Business Services Mfg Woodworking Machinery

2685 Mattison Ln, Santa Cruz, CA 95062
831 479-4944

Resumes

Senior Vice President Of Research And Manufacturing

view source

Location:

2561 Derby Dr, San Ramon, CA 94583

Industry:

Biotechnology

Work:

Bolt Biotherapeutics, Inc.
Senior Vice President of Research and Manufacturing
Bolt Biotherapeutics, Inc. Nov 2017 - Mar 2019
Senior Vice President of Research
Gilead Sciences Dec 1, 2016 - Nov 2017
Director and Head of Oncology Research
Gilead Sciences Jul 2012 - Dec 2016
Senior Research Scientist Ii, Oncology and Inflammation
Genentech Jun 1, 2011 - Jul 1, 2012
Senior Scientist

Education:

University of Dundee 1999 - 2002
Doctorates, Doctor of Philosophy, Biochemistry University of Strathclyde 1995 - 1999
Bachelors, Bachelor of Science, Molecular Biology, Biochemistry

Skills:

Biomarkers
Cancer
Cell
Oncology
Cancer Research
Biotechnology
Translational Research
Drug Discovery
Cell Biology
Elisa
Biomarker Discovery
Molecular Biology
Antibodies
Biochemistry
Target Identification
Assay Development
Immunology
Monoclonal Antibodies
Protein Purification
Cell Culture
Drug Development
Protein Chemistry
Genomics
Personalized Medicine
Molecular Diagnostics
In Vivo
Epigenetics
High Throughput Screening
Western Blotting
Protein Expression
Transfection
Qpcr
Drug Resistance
Tissue Culture
Dna
Molecular Cloning
Target Discovery and Validation
Team Leadership
Immuno Oncology

Interests:

Exercise
Sweepstakes
Home Improvement
Reading
Gourmet Cooking
Sports
Golf
Home Decoration
Health
Cooking
Cruises
Electronics
Crafts
Fitness
Music
Movies
Medicine
Diet
Walking
Travel
Career
Investing
Traveling
International Traavel

Languages:

English

David Dornan

view source

Location:

San Ramon, CA

Industry:

Marketing And Advertising

Work:

Kelly-Moore Paints
Part Time Sales
None at Present
Retired at None at Present

Education:

San Jose State University 1964 - 1968
Bachelors, Bachelor of Arts, Advertising, Journalism

Skills:

Customer Service
Training

David Dornan

view source

David Trent Rainy Dornan

view source

Us Patents

Anti-Cd79B Antibodies And Immunoconjugates And Methods Of Use
view source
US Patent:

8088378, Jan 3, 2012
Filed:

Jul 15, 2008
Appl. No.:

12/173465
Inventors:

Yvonne Chen - San Mateo CA, US
Mark Dennis - San Carlos CA, US
David Dornan - San Mateo CA, US
Kristi Elkins - San Francisco CA, US
Jagath Reddy Junutula - Fremont CA, US
Andrew Polson - San Francisco CA, US
Bing Zheng - Mountain View CA, US
Assignee:

Genetech Inc. - South San Francisco CA
International Classification:

A61K 39/396
C07K 16/28
US Classification:

4241331, 4241441, 4241531, 4241551, 4241561, 4241731, 4241741, 53038822, 5303873, 53038873, 5303888, 53038885
Abstract:

The present invention is directed to anti-CD79b antibody, huMA79b. v28, and compositions of matter thereof useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.

Anti-Cd79B Antibodies And Immunoconjugates And Methods Of Use
view source
US Patent:

8545850, Oct 1, 2013
Filed:

Nov 5, 2010
Appl. No.:

12/940435
Inventors:

Yvonne Chen - San Mateo CA, US
Mark Dennis - San Carlos CA, US
David Dornan - San Mateo CA, US
Kristi Elkins - San Francisco CA, US
Jagath Reddy Junutula - Fremont CA, US
Andrew Polson - San Francisco CA, US
Bing Zheng - Mountain View CA, US
Assignee:

Genentech, Inc. - South San Francisco CA
International Classification:

A61K 51/10
A61K 39/44
C07K 19/00
US Classification:

4241781, 4241791, 4241811, 4241831, 424 149, 424 153, 5303911, 5303915, 5303917, 5303919, 5303913
Abstract:

The present invention is directed to compositions of matter comprising immunoconjugates comprising an anti-CD79b antibody comprising: (i) an HVR-L1 sequence of KASQSVDYEGDSFLN (SEQ ID NO: 194), (ii) an HVR-L2 sequence of AASNLES (SEQ ID NO: 195), (iii) an HVR-L3 sequence of QQSNEDPLT (SEQ ID NO: 196), (iv) an HVR-H1 sequence of GYTFSSYWIE (SEQ ID NO: 202), (v) an HVR-H2 sequence of GEILPGGGDTNYNEIFKG (SEQ ID NO: 203), and (vi) an HVR-H3 sequence of TRRVPIRLDY (SEQ ID NO: 204) and to methods of using those compositions of matter for the treatment of hematopoietic tumor in mammals.

Cop1 Molecules And Uses Thereof
view source
US Patent:

20080009458, Jan 10, 2008
Filed:

Apr 10, 2007
Appl. No.:

11/786399
Inventors:

David Dornan - Burlingame CA, US
Dorothy French - San Carlos CA, US
Vishva Dixit - Los Altos CA, US
International Classification:

A61K 48/00
A61P 43/00
C12N 5/06
C12Q 1/68
G01N 33/00
US Classification:

514044000, 435029000, 435325000, 435375000, 435006000, 436086000
Abstract:

The invention provides diagnostic, prognostic, and therapeutic uses for detecting COP1 overexpression in a variety of cancers. The methods and uses can further include detecting p53 expression. The invention also provides reagents and kits for use in screening for test compounds that interfere with COP1 and p53 binding.

Phosphorylated Cop1 Molecules And Uses Thereof
view source
US Patent:

20080027004, Jan 31, 2008
Filed:

Dec 21, 2006
Appl. No.:

11/644293
Inventors:

David Dornan - Burlingame CA, US
Assignee:

Genentech, Inc. - South San Francisco CA
International Classification:

A61K 38/16
A61K 31/7088
A61P 35/00
C07K 14/00
C12N 1/00
C12N 5/06
G01N 33/00
C12Q 1/68
C12N 15/63
C07K 16/18
C07H 21/00
A61K 38/02
US Classification:

514013000, 435243000, 435320100, 435325000, 435006000, 436086000, 514002000, 514044000, 514789000, 530326000, 530387900, 536023100
Abstract:

The invention provides COP1 molecules and modulators of COP1 activity and methods of using them, including diagnostic and therapeutic uses thereof. Such molecules can be useful for detecting DNA damage and modulating the response to DNA damage and p53 activity in subjects. The invention also provides reagents and kits for use in screening for test compounds that can modulate COP1 activity.

Anti-Cd79B Antibodies And Immunoconjugates And Methods Of Use
view source
US Patent:

20100215669, Aug 26, 2010
Filed:

Jan 14, 2009
Appl. No.:

12/353917
Inventors:

Yvonne CHEN - San Mateo CA, US
Mark Dennis - San Carlos CA, US
David Dornan - San Mateo CA, US
Kristi Elkins - San Francisco CA, US
Jagath Reddy Junutula - Fremont CA, US
Andrew Polson - San Francisco CA, US
Assignee:

Genentech, Inc. - South San Francisco CA
International Classification:

A61K 39/395
C07K 16/28
C07H 21/04
C12N 15/63
C12N 5/10
C12P 21/02
C07K 17/02
G01N 33/53
C12N 5/0781
A61P 35/00
US Classification:

4241731, 5303896, 5303873, 536 2353, 4353201, 435325, 435 696, 53038822, 5303917, 5303919, 4241781, 435 71, 5303913, 4241811, 435375
Abstract:

The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.

Copi Molecules And Uses Thereof
view source
US Patent:

20110045474, Feb 24, 2011
Filed:

Jun 29, 2010
Appl. No.:

12/826537
Inventors:

David Dornan - Burlingame CA, US
Dorothy French - San Carlos CA, US
Vishva Dixit - Los Altos CA, US
International Classification:

C12Q 1/68
C12Q 1/00
G01N 33/53
US Classification:

435 6, 435 4, 435 71, 435 78
Abstract:

The invention provides diagnostic, prognostic, and therapeutic uses for detecting COP1 overexpression in a variety of cancers. The methods and uses can further include detecting p53 expression. The invention also provides reagents and kits for use in screening for test compounds that interfere with COP1 and p53 binding.

Methods And Compositions For Assessing Responsiveness Of B-Cell Lymphoma To Treatment With Anti-Cd40 Antibodies
view source
US Patent:

20110104671, May 5, 2011
Filed:

Nov 7, 2008
Appl. No.:

12/741814
Inventors:

David Dornan - San Mateo CA, US
Bart Burington - Oakland CA, US
International Classification:

C12Q 1/68
US Classification:

435 6
Abstract:

The invention provides methods and kits useful for predicting or assessing responsiveness of B-cell lymphoma to treatment with anti-CD40 antibodies.

Methods For Assessing Responsiveness Of B-Cell Lymphoma To Treatment With Anti-Cd40 Antibodies
view source
US Patent:

20120123695, May 17, 2012
Filed:

Apr 17, 2010
Appl. No.:

13/264973
Inventors:

David Dornan - San Mateo CA, US
Bart Burington - Oakland CA, US
International Classification:

G06F 19/24
C40B 40/06
G01N 33/566
C12Q 1/68
US Classification:

702 20, 435 612, 435 611, 506 16, 435 724, 435 71
Abstract:

The invention provides methods and kits useful for predicting or assessing responsiveness of a patient having B-cell lymphoma to treatment with anti-CD40 antibodies.